Search Results - "Blanken, Maarten"
-
1
Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Published in The New England journal of medicine (09-05-2013)“…In this randomized, placebo-controlled trial, otherwise healthy preterm infants received injections of palivizumab, a monoclonal antibody against respiratory…”
Get full text
Journal Article -
2
Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial
Published in The lancet respiratory medicine (01-04-2018)“…Respiratory syncytial virus (RSV) infection is associated with subsequent wheeze and asthma. We previously reported on the causal relationship between…”
Get full text
Journal Article -
3
Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy
Published in The Journal of infectious diseases (01-04-2017)“…Background. Respiratory syncytial virus (RSV) and human rhinovirus (HRV) are the most common viruses associated with acute respiratory tract infections in…”
Get full text
Journal Article -
4
Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study
Published in PloS one (12-03-2013)“…This study aimed to update and validate a prediction rule for respiratory syncytial virus (RSV) hospitalization in preterm infants 33-35 weeks gestational age…”
Get full text
Journal Article -
5
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants
Published in Pediatric pulmonology (01-05-2018)“…Background The objective was to develop a risk scoring tool which predicts respiratory syncytial virus hospitalisation (RSVH) in moderate‐late preterm infants…”
Get full text
Journal Article -
6
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
Published in European journal of pediatrics (01-01-2018)“…The objective of the paper is to assess the cost-effectiveness of targeted respiratory syncytial virus (RSV) prophylaxis based on a validated prediction rule…”
Get full text
Journal Article -
7
RSV hospitalization in infancy increases the risk of current wheeze at age 6 in late preterm born children without atopic predisposition
Published in European journal of pediatrics (01-04-2019)“…Severe respiratory syncytial virus (RSV) infection during infancy is associated with ongoing respiratory morbidity. In a large birth cohort of 2210 healthy…”
Get full text
Journal Article -
8
Respiratory Syncytial Virus and Recurrent Wheeze
Published in The New England journal of medicine (22-08-2013)“…To the Editor: In the randomized trial reported by Blanken et al. (May 9 issue), 1 the reduction of 9.7 percentage points in recurrent wheezing corresponds to…”
Get full text
Journal Article -
9
Correction to: Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
Published in European journal of pediatrics (01-02-2020)“…The name of the co-author Wendy J. Ungar was inadvertently omitted on the original published article. Her name and affiliation have now been added to the…”
Get full text
Journal Article -
10
Prediction model of RSV-hospitalization in late preterm infants: An update and validation study
Published in Early human development (01-04-2016)“…Abstract Background New vaccines and RSV therapeutics have been developed in the past decade. With approval of these new pharmaceuticals on the horizon, new…”
Get full text
Journal Article -
11
Cesarean section and hospitalization for respiratory syncytial virus infection
Published in The Pediatric infectious disease journal (01-02-2015)Get full text
Journal Article -
12
RSV prevention in infancy and asthma in later life – Authors' reply
Published in The lancet respiratory medicine (01-07-2018)Get full text
Journal Article -
13
Population-Attributable Risk of Risk Factors for Recurrent Wheezing in Moderate Preterm Infants During the First Year of Life
Published in Paediatric and perinatal epidemiology (01-07-2016)“…Background Recurrent wheezing in young infants has a high prevalence, influences quality of life, and generates substantial health care costs. We previously…”
Get full text
Journal Article -
14
Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Published in The New England journal of medicine (16-06-2016)“…Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants Original Article, N Engl J Med 2013;368:1791-1799. In the final paragraph of the…”
Get full text
Journal Article -
15
Viral respiratory burden in moderate-to-late preterm infants
Published in Early human development (01-06-2013)“…Summary More than 1 in 10 babies are born prematurely and most of them are born after gestational age 32 weeks. Mortality and morbidity are more common in…”
Get full text
Journal Article -
16
Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons
Published in The Pediatric infectious disease journal (01-02-2017)“…BACKGROUND:Moderate-late preterm infants, 33–35 weeks’ gestational age (wGA), are at increased risk for respiratory syncytial virus hospitalization (RSVH). The…”
Get full text
Journal Article -
17
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective Study
Published in The Pediatric infectious disease journal (01-01-2016)“…In several countries, respiratory syncytial virus prophylaxis is offered to late preterm infants who are at escalated risk of respiratory syncytial virus…”
Get full text
Journal Article -
18
Ethical considerations and rationale of the MAKI trial: A multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33–35 weeks
Published in Contemporary clinical trials (01-11-2012)“…Abstract Background Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is the most frequent cause of bronchiolitis during infancy…”
Get full text
Journal Article -
19
Ethical considerations and rationale of the MAKI trial: A multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33–35weeks
Published in Contemporary clinical trials (01-11-2012)“…Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is the most frequent cause of bronchiolitis during infancy. Long-term airway…”
Get full text
Journal Article -
20
Prospective Validation of a Prognostic Model for Respiratory Syncytial Virus Bronchiolitis in Late Preterm Infants: A Multicenter Birth Cohort Study. e59161
Published in PloS one (01-03-2013)“…Objectives This study aimed to update and validate a prediction rule for respiratory syncytial virus (RSV) hospitalization in preterm infants 33-35 weeks…”
Get full text
Journal Article